Isoflurane anesthesia induces liver injury by regulating the expression of insulin‑like growth factor 1

Zhu,Yingxian; Xiao,Xiaoyu; Li,Guowei; Bu,Juyuan; Zhou,Wenying; Zhou,Shaopeng

doi:10.3892/etm.2017.4157

Isoflurane anesthesia induces liver injury by regulating the expression of insulin‑like growth factor 1

Authors:
- Yingxian Zhu
- Xiaoyu Xiao
- Guowei Li
- Juyuan Bu
- Wenying Zhou
- Shaopeng Zhou
View Affiliations

Affiliations: Department of Anesthesiology, The Fifth Affiliated Hospital of Sun Yat‑Sen University, Zhuhai, Guangdong 519000, P.R. China, Department of Orthopaedics II, The Fifth Affiliated Hospital of Sun Yat‑Sen University, Zhuhai, Guangdong 519000, P.R. China, Department of General Surgery I, The Fifth Affiliated Hospital of Sun Yat‑Sen University, Zhuhai, Guangdong 519000, P.R. China, Department of Center Laboratory, The Fifth Affiliated Hospital of Sun Yat‑Sen University, Zhuhai, Guangdong 519000, P.R. China
Published online on: February 22, 2017 https://doi.org/10.3892/etm.2017.4157
Pages: 1608-1613

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

It has been suggested that isoflurane may cause perioperative liver injury. However, the mechanism of its action remains unknown. The purpose of the present study was to determine this possible mechanism. Sprague‑Dawley rats were randomly assigned into one of three groups (all n=12): Control group (exposed to mock anesthesia), isoflurane group (exposed to 2% isoflurane for 90 min), and isoflurane + insulin‑like growth factor 1 (IGF‑1) group (exposed to 2% isoflurane for 90 min and then treated with IGF‑1). Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blotting were conducted to determine the levels of expression of IGF‑1 and its receptor IGF‑R. Liver necrosis was assessed by histological examination. TUNEL assay was performed to determine the apoptosis of hepatic cells. In addition, the levels of the proteins caspase‑3 and B‑cell lymphoma‑extra large (Bcl‑xL) were measured. Compared with the control group, levels of IGF‑1 and IGF‑1R mRNA and protein were significantly decreased following exposure to isoflurane (all P<0.05). The necrosis rate and liver apoptosis were significantly increased in the group treated with isoflurane alone compared with the control group (P<0.05), but were significantly decreased compared with the isoflurane group following application of IGF‑1 (P<0.05). Additionally, isoflurane exposure significantly increased levels of caspase‑3 compared with the control group (P<0.05), but decreased levels of Bcl‑xL (P<0.05). By contrast, application of IGF‑1 reversed these changes. The present study therefore suggests that isoflurane induces liver injury in part by regulating the expression of IGF‑1 and that application of IGF‑1 may protect against liver injury induced by isoflurane exposure.

View Figures

View References

1	Njoku D, Laster MJ, Gong DH, Eger EI II, Reed GF and Martin JL: Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: Association between protein acylation and hepatic injury. Anesth Analg. 84:173–178. 1997. View Article : Google Scholar : PubMed/NCBI
2	Wright R, Eade OE, Chisholm M, Hawksley M, Lloyd B, Moles TM, Edwards JC and GArdner MJ: Controlled prospective study of the effect on liver function of multiple exposures to halothane. Lancet. 1:817–820. 1975. View Article : Google Scholar : PubMed/NCBI
3	Suliburk JW, Gonzalez EA, Kennison SD, Helmer KS and Mercer DW: Differential effects of anesthetics on endotoxin-induced liver injury. J Trauma. 58:711–717. 2005. View Article : Google Scholar : PubMed/NCBI
4	Mohseni M, Safari S and Alavian SM: Volatile anesthetics in ischemic liver injury: Enemy or friend? Hepat Mon. 14:e198802014. View Article : Google Scholar : PubMed/NCBI
5	Gunza JT and Pashayan AG: Postoperative elevation of serum transaminases following isoflurane anesthesia. J Clin Anesth. 4:336–341. 1992. View Article : Google Scholar : PubMed/NCBI
6	Brunt EM, White H, Marsh JW, Holtmann B and Peters MG: Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: A case report. Hepatology. 13:1017–1021. 1991. View Article : Google Scholar : PubMed/NCBI
7	Turner GB, O'Rourke D, Scott GO and Beringer TR: Fatal hepatotoxicity after re-exposure to isoflurane: A case report and review of the literature. Eur J Gastroenterol Hepatol. 12:955–959. 2000. View Article : Google Scholar : PubMed/NCBI
8	Carrigan TW and Straughen WJ: A report of hepatic necrosis and death following isoflurane anesthesia. Anesthesiology. 67:581–583. 1987. View Article : Google Scholar : PubMed/NCBI
9	Dabbagh A and Rajaei S: The role of anesthetic drugs in liver apoptosis. Hepat Mon. 13:e131622013. View Article : Google Scholar : PubMed/NCBI
10	Gelven PL, Cina SJ, Lee JD and Nichols CA: Massive hepatic necrosis and death following repeated isoflurane exposure: Case report and review of the literature. Am J Forensic Med Pathol. 17:61–64. 1996. View Article : Google Scholar : PubMed/NCBI
11	Kaseb AO, Morris JS, Hassan MM, Siddiqui AM, Lin E, Xiao L, Abdalla EK, Vauthey JN, Aloia TA, Krishnan S and Abbruzzese JL: Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma. J Clin Oncol. 29:3892–3899. 2011. View Article : Google Scholar : PubMed/NCBI
12	Sanz S, Pucilowska JB, Liu S, Rodríguez-Ortigosa CM, Lund PK, Brenner DA, Fuller CR, Simmons JG, Pardo A, Martínez-Chantar ML, et al: Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury. Gut. 54:134–141. 2005. View Article : Google Scholar : PubMed/NCBI
13	Svegliati-Baroni G, Ridolfi F, Di Sario A, Casini A, Marucci L, Gaggiotti G, Orlandoni P, Macarri G, Perego L, Benedetti A and Folli F: Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: Differential effects on signal transduction pathways. Hepatology. 29:1743–1751. 1999. View Article : Google Scholar : PubMed/NCBI
14	Aksu I, Baykara B, Kiray M, Gurpinar T, Sisman AR, Ekerbicer N, Tas A, Gokdemir-Yazar O and Uysal N: Serum IGF-1 levels correlate negatively to liver damage in diabetic rats. Biotech Histochem. 88:194–201. 2013. View Article : Google Scholar : PubMed/NCBI
15	Rehem RN and El-Shikh WM: Serum IGF-1, IGF-2 and IGFBP-3 as parameters in the assessment of liver dysfunction in patients with hepatic cirrhosis and in the diagnosis of hepatocellular carcinoma. Hepatogastroenterology. 58:949–954. 2011.PubMed/NCBI
16	Clemmons DR: Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin North Am. 41:425-443, vii-viii2012. View Article : Google Scholar
17	Friedman SL: Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 275:2247–2250. 2000. View Article : Google Scholar : PubMed/NCBI
18	Pinzani M, Abboud HE and Aron DC: Secretion of insulin-like growth factor-I and binding proteins by rat liver fat-storing cells: Regulatory role of platelet-derived growth factor. Endocrinology. 127:2343–2349. 1990. View Article : Google Scholar : PubMed/NCBI
19	Picardi A, de Oliveira AC, Muguerza B, Tosar A, Quiroga J, Castilla-Cortázar I, Santidrián S and Prieto J: Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis. J Hepatol. 26:191–202. 1997. View Article : Google Scholar : PubMed/NCBI
20	Edmands SD, Ladow E and Hall AC: Microarray analyses of genes regulated by isoflurane anesthesia in vivo: A novel approach to identifying potential preconditioning mechanisms. Anesth Analg. 116:589–595. 2013. View Article : Google Scholar : PubMed/NCBI
21	Vaquero J, Bélanger M, James L, Herrero R, Desjardins P, Côté J, Blei AT and Butterworth RF: Mild hypothermia attenuates liver injury and improves survival in mice with acetaminophen toxicity. Gastroenterology. 132:372–383. 2007. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Ozier Y and Klinck JR: Anesthetic management of hepatic transplantation. Curr Opin Anaesthesiol. 21:391–400. 2008. View Article : Google Scholar : PubMed/NCBI
24	Stoelting RK: Isoflurane and postoperative hepatic dysfunction. Can J Anaesth. 34:223–226. 1987.(In English, French). View Article : Google Scholar : PubMed/NCBI
25	Sinha A, Clatch RJ, Stuck G, Blumenthal SA and Patel SA: Isoflurane hepatotoxicity: A case report and review of the literature. Am J Gastroenterol. 91:2406–2409. 1996.PubMed/NCBI
26	Weitz J, Kienle P, Böhrer H, Hofmann W, Theilmann L and Otto G: Fatal hepatic necrosis after isoflurane anaesthesia. Anaesthesia. 52:892–895. 1997. View Article : Google Scholar : PubMed/NCBI
27	Cheng L, You Q, Yin H, Holt M, Franklin C and Ju C: Effect of polyI: C cotreatment on halothane-induced liver injury in mice. Hepatology. 49:215–226. 2009. View Article : Google Scholar : PubMed/NCBI
28	Jaeschke H, Gujral JS and Bajt ML: Apoptosis and necrosis in liver disease. Liver Int. 24:85–89. 2004. View Article : Google Scholar : PubMed/NCBI
29	Takahashi Y: Essential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liver. Endocr J. 59:955–962. 2012. View Article : Google Scholar : PubMed/NCBI
30	Bonefeld K and Møller S: Insulin-like growth factor-I and the liver. Liver Int. 31:911–919. 2011. View Article : Google Scholar : PubMed/NCBI
31	Caro JF, Poulos J, Ittoop O, Pories WJ, Flickinger EG and Sinha MK: Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver. J Clin Invest. 81:976–981. 1988. View Article : Google Scholar : PubMed/NCBI
32	Stefano JT, Correa-Giannella ML, Ribeiro CM, Alves VA, Massarollo PC, Machado MC and Giannella-Neto D: Increased hepatic expression of insulin-like growth factor-I receptor in chronic hepatitis C. World J Gastroenterol. 12:3821–3828. 2006. View Article : Google Scholar : PubMed/NCBI
33	Kim SO, Park JG and Lee YI: Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: Implications of IGF-I receptor gene activation by hepatitis B virus X gene product. Cancer Res. 56:3831–3836. 1996.PubMed/NCBI
34	Bugianesi E, McCullough AJ and Marchesini G: Insulin resistance: A metabolic pathway to chronic liver disease. Hepatology. 42:987–1000. 2005. View Article : Google Scholar : PubMed/NCBI
35	Mantena SK, King AL, Andringa KK, Eccleston HB and Bailey SM: Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol Med. 44:1259–1272. 2008. View Article : Google Scholar : PubMed/NCBI
36	Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W and Le Roith D: Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes. 50:1110–1118. 2001. View Article : Google Scholar : PubMed/NCBI
37	Conchillo M, de Knegt RJ, Payeras M, Quiroga J, Sangro B, Herrero JI, Castilla-Cortazar I, Frystyk J, Flyvbjerg A, Yoshizawa C, et al: Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: Results of a pilot randomized controlled clinical trial. J Hepatol. 43:630–636. 2005. View Article : Google Scholar : PubMed/NCBI
38	Hao CN, Geng YJ, Li F, Yang T, Su DF, Duan JL and Li Y: Insulin-like growth factor-1 receptor activation prevents hydrogen peroxide-induced oxidative stress, mitochondrial dysfunction and apoptosis. Apoptosis. 16:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
39	Nishizawa H, Takahashi M, Fukuoka H, Iguchi G, Kitazawa R and Takahashi Y: GH-independent IGF-I action is essential to prevent the development of nonalcoholic steatohepatitis in a GH-deficient rat model. Biochem Biophys Res Commun. 423:295–300. 2012. View Article : Google Scholar : PubMed/NCBI
40	Pérez R, Garcia-Fernández M, Díaz-Sánchez M, Puche JE, Delgado G, Conchillo M and Muntané J and Castilla-Cortázar I: Mitochondrial protection by low doses of insulin-like growth factor-I in experimental cirrhosis. World J Gastroenterol. 14:2731–2739. 2008. View Article : Google Scholar : PubMed/NCBI
41	Canbay A, Feldstein AE, Higuchi H, Werneburg N, Grambihler A, Bronk SF and Gores GJ: Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology. 38:1188–1198. 2003. View Article : Google Scholar : PubMed/NCBI
42	Sattler M, Liang H, Nettesheim D, Meadows RP, Harlan JE, Eberstadt M, Yoon HS, Shuker SB, Chang BS, Minn AJ, et al: Structure of Bcl-xL-Bak peptide complex: Recognition between regulators of apoptosis. Science. 275:983–986. 1997. View Article : Google Scholar : PubMed/NCBI
43	Ku B, Liang C, Jung JU and Oh BH: Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX. Cell Res. 21:627–641. 2011. View Article : Google Scholar : PubMed/NCBI
44	Gottschalk S, Zwingmann C, Raymond VA, Hohnholt MC, Chan TS and Bilodeau M: Hepatocellular apoptosis in mice is associated with early upregulation of mitochondrial glucose metabolism. Apoptosis. 17:143–153. 2012. View Article : Google Scholar : PubMed/NCBI
45	Dejean LM, Ryu SY, Martinez-Caballero S, Teijido O, Peixoto PM and Kinnally KW: MAC and Bcl-2 family proteins conspire in a deadly plot. Biochim Biophys Acta. 1797:1231–1238. 2010. View Article : Google Scholar : PubMed/NCBI
46	Stevens MF, Werdehausen R, Gaza N, Hermanns H, Kremer D, Bauer I, Küry P, Hollmann MW and Braun S: Midazolam activates the intrinsic pathway of apoptosis independent of benzodiazepine and death receptor signaling. Reg Anesth Pain Med. 36:343–349. 2011. View Article : Google Scholar : PubMed/NCBI
47	Porter AG and Jänicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999. View Article : Google Scholar : PubMed/NCBI